ESTIMATION OF COVID-19 CASES IN FRANCE AND IN DIFFERENT COUNTRIES: HOMOGENEISATION BASED ON MORTALITY

Marc Dhenain

doi:10.1101/2020.04.07.20055913

Abstract

Every day the authorities of different countries provide an estimate of the number of persons affected by Covid-19 and a count of mortality. We propose to use the mortality reported in each country to provide a better estimate (C_t0-estimated) of the number of cases at a given time t₀.

With M_t0: number of deaths reported in a country at time t₀; M_r-est: estimated mortality rate; C_t0: number of cases reported in a country at time t₀; C_to-18d: number of cases reported in the country at time t0 minus 18 days.

Based on this index and an estimated mortality rate of 2%, we assessed the number of cases April 2, 2020 in Belgium, China, France, Germany, Iran, Italy, South Korea, Netherlands, Spain, United Kingdom and USA. This number reaches 3,538,549 in France and 809,896 persons in Germany. The proposed formula also makes it possible to evaluate the impact of policies to prevent the spread of epidemic on the appearance of new cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received to perform this study.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available from: https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series

https://github.com/CSSEGISandData/COVID-19/tree/master/csse_covid_19_data/csse_covid_19_time_series

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.